The UNC School of Medicine Office of Graduate Education published findings in PLOS Biology showing that graduate students who partake in professional development opportunities unrelated to their lab work did…
Ed Browne, PhD, assistant professor of medicine, is the principal investigator of a $4-million, 5-year study of the role of cannabis use in HIV latency – one of the main…
Damaris Lorenzo, PhD, at the UNC School of Medicine, led the discovery of a new neurodevelopmental syndrome, its underlying genetic basis and molecular mechanisms, both important milestones on the road…
Led by John Batsis, MD, researchers completed a comprehensive review of 315 existing clinical trials of weight loss supplements and therapies, and most of the studies showed the supplements did…
Led by Katie Baldwin, PhD, research published in Neuron shows how the loss of the protein hepaCAM drives brain development dysfunction and plays an important role in neurological disorders.
UNC School of Medicine scientists led by Aravinda de Silva, PhD, identified the small subpopulation of antibodies in vaccinated children that correlate with protection against dengue fever. This research should…
Immunology And Microbiology, Infectious Diseases, News, Research
Led by John Buse, MD, PhD, and Anna Kahkoska, MD, PhD, this analysis showed that GLP1-RA and SGLT2i medication use for type 2 diabetes of hospitalized COVID-19 patients was associated…
NC State researchers led by Ke Cheng, PhD, created a therapeutic approach that mimics the receptor that the virus binds to and then traps the virus before it infect cells….
James F. Howard Jr., MD, Distinguished Professor in the UNC Department of Neurology, was principal investigator of the promising phase 3 trial for the experimental drug efgartigimod.
Scientists led by UNC School of Medicine researchers Silvia Kreda, PhD, and Rudolph Juliano, PhD, created an improved oligonucleotide therapy strategy with the potential for treating other pulmonary diseases, such…
This pre-clinical research offers evidence that vaccinating young children could help prevent the spread of COVID-19, limit disease severity, and achieve herd immunity.
The UNC School of Medicine lab of Mehmet Kesimer, PhD, discovered MUC5AC is more reliably associated with the manifestation of COPD than another well-known mucus protein, revealing a possible biomarker…
The UNC School of Medicine labs of Pengda Liu, PhD, and Guochun Jiang, PhD, led work to show how the drug lenalidomide can disrupt the pseudo-coronavirus’s ability to infect human…
UNC-Chapel Hill and Duke researchers promote better health through gamification. The study was co-led by Lisa Hightow-Weidman, MD, MPH, at the UNC School of Medicine, and Kate Meussig, Phd, at…
UNC School of Medicine’s David Peden, MD, is the UNC site principal investigator of the NIH-sponsored study, and Scott Commins, MD, PhD, is co-PI. Participants can now enroll at UNC-Chapel…
UNC-Chapel Hill scientists discovered microRNA-29 is an important cellular switch controlling late-stage brain development, a foundational discovery that will help researchers explore new therapeutic approaches for neurodevelopmental conditions.
Participating households in Greenville, Pitt County, NC will receive free month-long supplies of rapid tests aimed at reducing community transmission of COVID-19. UNC School of Medicine’s Giselle Corbie-Smith, MD, and…
Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that the widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
A pilot study from researchers at NC State and UNC school of Medicine shows evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. Flavio Frohlich,…
Researchers in the UNC School of Medicine Lab of Thomas Kash, PhD, published new findings in the journal Neuron showing how neurons in two brain regions use dopamine to promote…
